BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8097955)

  • 1. Renal imidazoline preferring sites and solute excretion in the rat.
    Allan DR; Penner SB; Smyth DD
    Br J Pharmacol; 1993 Apr; 108(4):870-5. PubMed ID: 8097955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and renal I1 imidazoline preferring receptors: two unique sites mediating natriuresis in the rat.
    Penner SB; Smyth DD
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():43-8. PubMed ID: 7915136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine.
    Allan DR; Penner SB; Smyth DD
    Br J Pharmacol; 1996 Jan; 117(1):29-34. PubMed ID: 8825339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral and central imidazoline receptor-mediated natriuresis in the rat.
    Smyth DD; Penner SB
    Ann N Y Acad Sci; 1999 Jun; 881():344-57. PubMed ID: 10415934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazoline receptor mediated natriuresis: central and/or peripheral effect?
    Smyth DD; Penner SB
    J Auton Nerv Syst; 1998 Oct; 72(2-3):155-62. PubMed ID: 9851564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the peripheral sympathetic nervous system in the natriuresis following central administration of an I1 imidazoline agonist, moxonidine.
    Penner SB; Smyth DD
    Br J Pharmacol; 1995 Nov; 116(6):2631-6. PubMed ID: 8590981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the natriuretic action of the imidazoline receptor agonist moxonidine by indometacin in the rat.
    Darkwa FK; Smyth DD
    Pharmacology; 1995 Dec; 51(6):347-55. PubMed ID: 8966191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats.
    Li P; Penner SB; Smyth DD
    Br J Pharmacol; 1994 May; 112(1):200-6. PubMed ID: 8032642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed renal response to 2,6-dimethyl clonidine but not clonidine in one kidney-one clip hypertensive rats.
    Li P; Smyth DD
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1395-400. PubMed ID: 7903388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium excretion following central administration of an I1 imidazoline receptor agonist, moxonidine.
    Penner SB; Smyth DD
    Br J Pharmacol; 1994 Aug; 112(4):1089-94. PubMed ID: 7952868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and blood pressure effects of moxonidine and clonidine in spontaneously hypertensive rats.
    Hohage H; Hess K; Jahl C; Greven J; Schlatter E
    Clin Nephrol; 1997 Dec; 48(6):346-52. PubMed ID: 9438092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of central alpha1-adrenoceptors on renal responses to central moxonidine and alpha-methylnoradrenaline.
    de Andrade CA; de Andrade GM; De Paula PM; De Luca LA; Menani JV
    Eur J Pharmacol; 2009 Apr; 607(1-3):60-7. PubMed ID: 19326476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent absence of direct renal effect of imidazoline receptor agonists.
    Smyth DD; Pirnat D; Forzley B; Penner SB
    Ann N Y Acad Sci; 2003 Dec; 1009():288-95. PubMed ID: 15028602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of moxonidine and clonidine on potassium excretion in Sprague-Dawley rats.
    Hohage H; Mehrens T; Matzkies F; Steinmetz M; Greven J
    Pharmacol Res; 1999 May; 39(5):357-61. PubMed ID: 10328993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
    Cao C; Kang CW; Kim SZ; Kim SH
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of forebrain imidazoline and alpha(2)-adrenergic receptors in the antidipsogenic response to moxonidine.
    Andrade CA; Oliveira LB; Martinez G; Silva DC; De Luca LA; Menani JV
    Ann N Y Acad Sci; 2003 Dec; 1009():262-4. PubMed ID: 15028596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.